We also showed increased phospho-NF-κB activation in DCs cocultured with ASCA IgGs, predominantly up to 6 years before diagnosis (Fig. 3f), suggesting that the NF-κB signaling pathway is modulated by ASCA IgG glycoprofiles in the preclinical phase of CD. Here, NFKB1 is linked to Cowden disease.